Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-08

Clinical Trial Update: Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) [NA]

View source ↗

Summary

ClinicalTrials.gov update notes the ASPIRIN trial evaluating aspirin supplementation during pregnancy to reduce risk of premature birth in nulliparous women has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: NICHD Global Network for Women's and Children's Health | Conditions: Premature Birth | NA | Status: COMPLETED | Results posted: 2021-09-08